Valo is a technology company built to transform the drug discovery and development process using human-centric data and AI-powered computation. Valo is fully integrating human-centric data across the entire drug development lifecycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing the cost, time, and failure rate. The company’s Opal Computational Platform™ consists of an integrated set of capabilities designed to transform data into valuable insights that may accelerate discoveries and enable Valo to advance a robust pipeline of programs across cardiovascular metabolic renal, oncology, and neurodegenerative disease.
| Website | http://www.valohealth.com |
| Revenue | $127.3 million |
| Employees | 170 (166 on RocketReach) |
| Founded | 2019 |
| Technologies |
JavaScript
,
PHP
,
Twitter
+41 more
(view full list)
|
| Industry | Biotechnology Research, Business/Productivity Software |
| Keywords | Drug Discovery, Drug Development, Ai In Healthcare, Data Driven Healthcare, Ai Drug Discovery, Technology In Healthcare, Biotechnology, Pharmaceutical Technology, Precision Medicine, Clinical Trials, Healthtech, Life Sciences, Machine Learning Healthcare, Computational Biology, Digital Health, Data Analytics Healthcare, Bioinformatics, Therapeutics |
| Competitors | Roche, Novartis, Merck AH, Pfizer, Bristol Myers Squibb, Genentech, Amgen, Gilead Sciences, Biogen, Lilly India +43 more (view full list) |
Looking for a particular Valo employee's phone or email?
The Valo annual revenue was $127.3 million in 2026.
Brian Alexander is the CEO of Valo.
166 people are employed at Valo.
Valo is based in Boston, Massachusetts.